ANALGESIC NEPHROPATHY. A MODERN VIEW ON THE PROBLEM
https://doi.org/10.25207/1608-6228-2019-26-2-191-201
Abstract
Aim. To review Russian and foreign literature on modern methods of diagnosis and treatment of patients with analgesic nephropathy.
Materials and methods. Russian and foreign literature sources published in recent years on the aforementioned problem were analyzed.
Results. This article presents the concept of analgesic nephropathy (AN) and discusses causes and mechanisms of its development. The pathogenic effect of non-steroidal antiinfl ammatory drugs on renal tissue is indicated. Key stages of the disease and its clinical features are determined. An algorithm of diagnosis is proposed. The importance of a patient’s detailed medical history is emphasized, including the duration, multiplicity and reasons for taking analgesics. A particular attention is paid to questions of AN therapy and its prevention. Provided timely diagnosis and analgesics withdrawal, the possibility of reverting tubulointerstitial infl ammation is shown.
Conclusion. It is shown that optimal solutions with regard to AN diagnosis and its treatment are yet to be found. A timely diagnosis inhibits the development of chronic renal failure, which early detection provides for a higher treatment effi ciency and improved prognosis.
About the Author
Olga B. Poselugina
Tver State Medical University, Ministry of Healthcare of the Russian Federation
Russian Federation
Russian Federation
Dr. Sci. (Med.), Assoc. Prof., Department of Hospital Therapy and Occupational Diseases,
1 Suvorova str., 11-87, Tver, 170002
References
1. Androsova S. O., Nikulina E. N. Ostryi tubulointerstitsial’nyi nefrit u bol’noi s anal’geticheskoi nefropatiei. Praktikuyushchii Vrach. 1997; 1: 20–21 (In Russ.).
2. Balkarov I. M., Lebedeva M. V., Shcherbak A. V., Mukhin N. A. Klinika. Diagnostika i lechenie khronicheskogo tubulointerstitsial’nogo nefrita. Klinicheskaya Farmakologiya i Terapiya. 2000; 9(5): 81–85 (In Russ.).
3. Batyushin M. M., Dmitrieva O. V., Terent’ev V. P. Rol’ anal’getikov i nesteroidnykh protivovospalitel’nykh preparatov v razvitii interstitsial’nykh porazhenii pochec. Nefrologiya i Dializ. 2006; 3: 239–244 (In Russ.).
4. Batyushin M. M., Povilaite P. E. Klinicheskaya nefrologiya. Rukovodstvo. Elista: ZAOr NPP «Dzhangar»; 2009. 656 р. (In Russ.).
5. Batyushin M. M., Dmitrieva O. V., Terent’ev V. P., Davidenko K. S. Raschetnye metody prognosirovanya riska razvitiya analgeticheskogo intersticialnogo porajenia pochec. Terapevticheskii Arkhiv. 2008; 6: 62–65 (In Russ.).
6. Batyushin M. M., Matsionis A. E., Povilaitite P. E., Dmitrieva O. V., Terent’ev V. P. A clinical-morphological analysis of the medicinal kidney lesions during therapy with non-steroid anti-infl ammatory drugs. Nefrologiya i Dializ. 2009; 11(1):44–48 (In Russ., English abstract).
7. Demchenko V. I., Korzhov I. S. Nefrologiya. Uchebno-metodicheskoe posobie. Omsk: OmGMA; 2008. 458 р. (In Russ.).
8. Zborovskii A. B., Tyurenkov I. N. Oslozhneniya farmakoterapii. Rukovodstvo dlya vrachei. Moscow: Meditsina; 2003. 544 р. (In Russ.).
9. Klinicheskie rekomendatsii po diagnostike i lecheniyu ostrogo tubulointerstitsial’nogo nefrita. Developer: Nauchnoe obshchestvo nefrologov Rossii. Working group: Shilov E. M., Batyushin M. M. 2015. 17 р. (In Russ.).
10. Klinicheskie rekomendatsii po diagnostike i lecheniyu khronicheskogo tubulointerstitsial’nogo nefrita. Developer: Associacia nefrologov. Nauchnoe obshestvo nefrologov Rossii. 2015. 17 р. (In Russ.).
11. Mukhin N. A., Moiseev V. S., Martynov A. I. (editors). Vnutrennie bolezni. In 2 vol. V. 1: Vnutrennie bolezni. Moscow: GEOTAR-Media; 2004. 648 р. (In Russ.).
12. Diagnostika i lechenie anemii pri khronicheskoi bolezni pochek. Assotsiatsiya nefrologov Rossii. Rossiiskoe Dializnoe Obshchestvo, Nauchnoe obshchestvo nefrologov Rossii. Natsional’nye rekomendatsii. 2014. 34 р. (In Russ.).
13. Mukhin N. A., editor. Nefrologiya: natsional’noe rukovodstvo. Moscow: GEOTAR-Media; 2009. 720 р. (In Russ.).
14. Nikolaev A.Yu., Lifshits N. L., Ermolenko V. I. Opyt dlitel’nogo primeneniya malobelkovoi diety pri khronicheskoi pochechnoi nedostatochnosti. Terapevticheskii Arkhiv. 1994; 66(6): 45–57 (In Russ.).
15. Sheiman D. A., editor. Patofi ziologiya pochki. Moscow: «Izdatel’stvo BINOM»; 2013. 206 р. (In Russ.).
16. Batyushin M. M., Martirosov V.Yu., editors. Protokoly (standarty) diagnostiki i lecheniya v nefrologii: metodicheskie ukazaniya. Rostov-na-Donu: izd-vo RostGMU; 2004. 129 р. (In Russ.).
17. Shraier R. V., editor. Rukovodstvo po nefrologii. Moscow: GEOTAR-Media; 2009. 560 р. (In Russ.).
18. Tareeva I. E., Nikolaev A.Yu., Androsova S. O. Lekarstvennye Terapevticheskii Arkhiv porazheniya pochek. In: Tareeva I. E., editor. Nefrologiya. M.: Meditsina; 1995. 299–312 (In Russ.).
19. Tareeva I. E. Tubulointerstitsial’nye nefropatii. In: Тareeva I. E., editor. Nefrologiya. M.: Meditsina; 1995. 101–110 (In Russ.).
20. Shilov E. M., Androsova S. Lekarstvennye porazheniya pochek. Vrach. 2002; 6: 47–49 (In Russ.).
21. Shilov E. M. Nefrologiya. Rukovodstvo. Moscow: GEOTAR-Media; 2007. 450 р. (In Russ.).
22. Shilo V. U., Hasabov N. N. Anemia pri chronicheskoy bolezni pochec. Lechashy Vrach. 2008; 8: 23–30.
23. Akhund L., Quinet R. J., Ishaq S. Celecoxib-related papillary necrosis. Arch. Intern. Med. 2003; 163(1): 114–115.
24. Ayasreh F. N., Ars C. Е., Lopes M. V., Arce T. Y., Ruiz D. P., Ballarín C. J., Torra B. R. Familial chronic interstitial nephropathy with hyperuricaemia caused by the UMOD gene. Nefrologia (English Version). 2013; 33: 587–592. DOI: 10.3265/Nefrologia.pre2013. Apr.11960
25. Blatt A. E., Liebman S. E. Drug induced acute kidney injury. Hosp. Med. Clin. 2013; 2: 525–541.
26. Bomback A. S., Markowitz G. S. Increased prevalence of acute interstitial nephritis: more disease or simply more detection? Nephrol. Dial. Transplant. 2013; 28(1): 16–18.
27. Bouvy M. L., Heerdink E. R., Hoes A. W., Leufkens H. G. Effects of NSAIDs on the incidence of hospitalisations for renal dysfunction in users of ACE inhibitors. Drug Saf. 2003; 26(13): 983–989. DOI: 10.2165/00002018-200326130-00006
28. Brater D. C. Anti-infl ammatory agents and renal function Semin. Arthritis Rheum. 2002; 32 (Suppl 1): 33– 42.
29. Clarkson M. R., Giblin L., O’Connell F. P., O’Kelly P., Walshe J. J., Conlon Р., O’Meara Y., Dormon А., Campbell Е., Donohoe J. Acute interstitial nephritis: clinical features and response to corticosteroid therapy. Nephrol. Dial. Transplant. 2004; 19(11): 2778– 2783.
30. Ekici A. B., Hackenbeck T., Morinière V., Pannes A., Buettner M., Uebe S., Janka R., Wiesener A., Hermann I., Grupp S., Hornberger M., Huber T. B., Isbel N., Mangos G., McGinn S., Soreth-Rieke D., Beck B. B., Uder M., Amann K., Antignac C., Reis A., Eckardt K. U., Wiesener M. S. Renal fi brosis is the common feature of autosomal dominant tubulointerstitial kidney diseases caused by mutations in mucin 1 or uromodulin. Kidney Int. 2014; 86(3): 589–599. DOI: 10.1038/ki.2014.72
31. Elseviers M. M., De Broe M. E. Tubulointerstitial kidney diseases. Am. J. Kidney Dis. 1996; 28: 48–55.
32. Feinstein A. R., Heinemann L. A., Curhan G. C., Delzell E., Deschepper P. J., Fox J. M., Graf H., Luft F. C., Michielsen P., Mihatsch M. J., Suissa S., Van Der Woude F., Willich S. Relationship between nonphenacetin combined analgesics and nephropathy: a review. Ad Hoc Committee of the International Study Group on Analgesics and Nephropathy. Kidney Int. 2000; 58(6): 2259–2264. DOI: 10.1046/j.1523- 1755.2000.00410.x
33. Galesic K., Morovic-Vergles J., Jelakovic B. Nonsteroidal antirheumatics and the kidney. Reumatizam. 2005; 52(2): 61–66.
34. Gooch K., Culleton B. F., Manns B. J., Zhang J., Alfonso H., Tonelli M., Frank C., Klarenbach S., Hemmelgarn B. R. NSAID use and progression of chronic kidney disease. Am. J. Med. 2007; 120(3): 280.e1-е7. DOI: 10.1016/j.amjmed.2006.02.015
35. Lanas A., Benito P., Alonso J., Hernández-Cruz B., Barón-Esquivias G., Perez-Aísa Á., Calvet X., GarcíaLlorente J. F., Gobbo M., Gonzalez-Juanatey J. R. Safe prescription recommendations for non steroidal anti-infl ammatory drugs: consensus document ellaborated by nominated experts of three scientifi c associations (SER-SEC-AEG). Reumatol. Clin. 2014; 10(2): 68–84. DOI: 10.1016/j.reuma.2013.10.004
36. Leven C., Hudier L., Picard S., Longuet H., Lorcy N., Cam G., Boukerroucha Z., Dolley-Hitze T., Le Cacheux P., Halimi J. M., Cornec Le Gall E., Hanrotel-Saliou C., Arreule A., Massad M., Duveau A., Couvrat-Desvergnes G., Renaudineau E. Prospective study of drug-induced interstitial nephritis in eleven French nephrology units. Presse Med. 2014; 43(11): 369–376. DOI: 10.1016/j.lpm.2014.03.032
37. Nanayakkara S., Senevirathna S. T., Abeysekera T., et al. An integrativestudy of the genetic, social and environmental determinants of chronic kidney disease characterized by tubulointerstitial damages in the North Central Region of Sri Lanka. J. Occup. Health. 2014; 56(1): 28–38.
38. Plantinga L., Grubbs V., Sarkar U., Hsu C. Y., Hedgeman E., Robinson B., Saran R., Geiss L., Burrows N. R., Eberhardt M., Powe N. Nonsteroidal anti-infl ammatory drug use among persons with chronic kidney disease in the United States. Ann. Fam. Med. 2011; 9(5): 423–430. DOI: 10.1370/afm.1302
Review
For citations:
Poselugina O.B. ANALGESIC NEPHROPATHY. A MODERN VIEW ON THE PROBLEM. Kuban Scientific Medical Bulletin. 2019;26(2):191-201. (In Russ.) https://doi.org/10.25207/1608-6228-2019-26-2-191-201
Views:
1152
Email this article 